Muscarinic-receptor antagonist scopolamine rescues hippocampal neurons from death induced by glutamate

Brain Research

Volumn 788, Issue 1-2, 1998, Pages 323-326

  Rami, A ^a   Krieglstein, J ^b  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^b Inst of Pharmacology and Toxicology   (Germany)

Author keywords

Excitatory amino acid; Muscarinic receptor; Neurotoxicity; Scopolamine

Indexed keywords

GLUTAMIC ACID; MUSCARINIC RECEPTOR BLOCKING AGENT; SCOPOLAMINE;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; GLIA CELL; HIPPOCAMPUS; NERVE CELL NECROSIS; NERVE DEGENERATION; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; CELL DEATH; CELLS, CULTURED; EXCITATORY AMINO ACID ANTAGONISTS; GLUTAMIC ACID; MUSCARINIC ANTAGONISTS; NEURONS; NEUROTOXINS; RATS; RATS, INBRED F344; SCOPOLAMINE;

EID: 0032579789     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(98)00041-9     Document Type: Article

References (19)

1. Benveniste H., Drejer J., Schousboe A., Diemer N.H. Elevation of extracellular concentrations of glutamate and aspartate in rat hippocampus during transient cerebral ischemia monitored by intracerebral microdialysis. J. Neurochem. 43:1984;1369-1374.
2. Bernardo L.S., Prince D.A. Acetylcholine-induced modulation of hippocampal neurons. Brain Res. 211:1981;227-234.
3. Bockaert J., Pin J., Fagni L. Metabotropic glutamate receptors, an original family of G-protein-coupled receptors. Fundam. Clin. Pharmacol. 7:1993;473-485.
4. Bliss T.V., Lomo T. Long-lasting potentiation of synaptic transmission in the dentate area of the anesthetized rabbit following stimulation of the perforant path. J. Physiol. 232:1973;331-356.
5. Buchan A.M., Pulsinelli W.A. Septo-hippocampal deafferentation protects CA1 neurons against injury. Brain Res. 512:1989;7-14.
6. Choi D.W. Glutamate neurotoxicity and diseases of the nervous system. Neuron. 1:1988;623-634.
7. Hollmann M., Heinemann S. Cloned glutamate receptors. Annu. Rev. Neurosci. 17:1994;31-108.
8. Kleschevnikov A.M., Sinden J.D., Marchbanks R. Fimbria-fornix lesions impair spatial performance and induce epileptic-like activity but do not affect long-term potentiation in the CA1 region of rat hippocampal slices. Brain Res. 656:1994;221-228.
9. Koh J.I., Choi D.W. Vulnerability of cultured cortical neurons to damage by excitotoxins: differential susceptibility of neurons containing NADPH-diaphorase. J. Neurosci. 8:1988;2153-2163.
10. 2+ concentration. Neurosci. Lett. 85:1988;345-350.
11. Lyeth B.G., Hayes R.L. Cholinergic and opioid mediation of traumatic brain injury. J. Neurotrauma. 9:1992;463-474.
12. G. Lynch, G. Rose, C. Gall, Anatomical and functional aspects of the septohippocampal, in: K. Elliot et al. (Eds.), Functions of the Septohippocampal System, Elsevier, Amsterdam, 1987, pp. 5-24.
13. Markram H., Segal M. The inositol-1,4,5-triphosphate pathway mediates cholinergic potentiation of rat hippocampal neuronal responses to NMDA. J. Physiol. 447:1992;513-533.
14. Mattson M.P. Acetylcholine potentiates glutamate-induced neurodegeneration in cultured hippocampal neurons. Brain Res. 497:1989;402-406.
15. Mattson M.P., Barger S.W., Begley J., Mark R.J. Calcium, free radicals and excitotoxic neuronal death in primary cell culture. Methods Cell Biol. 46:1995;187-216.
16. Onodera H., Sato G., Kogure K. Quantitative autoradiographic analysis of muscarinic adenosine A1 binding sites after transient forebrain ischemia in the gerbil. Brain Res. 415:1987;309-322.
17. Rothman S.M. Synaptic release of excitatory amino acid neurotransmitter mediates anoxic neuronal death. J. Neurosci. 4:1984;1884-1891.
18. Rothman S.M., Onley J.W. Excitotoxicity and the NMDA receptor. Trends Neurosci. 10:1987;299-302.
19. Wieloch T., Lindvall O., Blomqvist P., Gage F. Evidence for amelioration of ischemic neuronal damage in the hippocampal formation by lesions of the perforant path. Neurol. Res. 7:1985;24-26.